Although, Wu et al. 31, showed that CMLD-2 exerts its antitumor activity by disrupting the interaction between HuR protein and its target mRNAs, the binding affinity to HuR in tumor cells versus normal cells have not been studied. This evidence concerns the gene ELAVL1 and neoplasm.